Skip to main content
. 2023 Oct 14;11(10):2791. doi: 10.3390/biomedicines11102791

Table 5.

Comparison of the tumor necrosis factors, SCD40L, and chemokines levels according to the HOMA-IR index.

Analytes HOMA < 2.5 (n = 24) HOMA ≥ 2.5 (n = 20) p
SCD40L 193.5 (156.6–439.8) 271.6 (170.4–400) 0.494
TNF-α 16.5 (12.4–22.5) 11.5 (10–20.3) 0.069
TNF-β 9.4 (5.2–16.3) 4.9 (1.8–16.9) 0.268
FKN 147.3 (130.7–241.2) 130.7 (101.6–204.8) 0.140
MIG 685.7 (535.7–842.3) 693.7 (574.5–772.1) 0.786
GRO-α 1.14 (0.42–2.94) 0.42 (0.12–1.81) 0.126
MCP-1 166.2 (139.5–189.3) 154 (101.5–191) 0.258
MCP-3 11.9 (6.5–20.8) 8.4 (4.9–20.4) 0.457
MIP-1α 15.9 (8.0–29.6) 18.2 (10.6–25.9) 0.972
MIP-1β 16.7 (12.5–20.4) 18.6 (14.9–22.5) 0.216
Eotaxin 53.9 (44.9–63.9) 37.4 (30–45) 0.001

SCD40L—soluble CD40 and its ligand, TNF-α—tumor necrosis factor alpha, TNF-β—tumor necrosis factor beta, FKN—fractalkine, GROa—chemokine ligand 1, MIG—monokine-induced gamma interferon, MCP-1—monocyte-chemoattractant protein 1, MCP-3—monocyte-chemotactic protein 3, MIP-1α—macrophage inflammatory protein 1-alpha, MIP-1β—macrophage inflammatory protein 1-beta.